Publications That Use U.S. Cancer Statistics Data

U.S. Cancer Statistics data are used by CDC researchers, cancer registry program staff, academic and medical researchers, and others to advance scientific knowledge and reduce the burden of cancer. Stat bites, data briefs, and a selection of peer-reviewed journal articles using U.S. Cancer Statistics data are highlighted below.

Stat Bites

Current U.S. Cancer Statistics Data Briefs

Testicular Cancer Incidence by Tumor Type and Age New
April 2024
Gastrointestinal Cancer in American Indian and Alaska Native People New
Number 36, November 2023
U.S. Cancer Statistics: Highlights from 2020 Mortality and Incidence with Comparison to 2019 Incidence to Assess the Effect of the COVID-19 Pandemic New
Number 35, June 2023
Prostate Cancer Incidence by Stage at Diagnosis, United States—2001−2019
Number 34, April 2023
Colorectal Cancer Incidence, United States—2003−2019
Number 33, March 2023

Selected Journal Articles

Chang SH, Patel N, Du M, Liang PS. Trends in early-onset vs late-onset colorectal cancer incidence by race/ethnicity in the United States Cancer Statistics database. Clinical Gastroenterology and Hepatology 2022;20(6):e1365–e1377. 10.1016/j.cgh.2021.07.035
Ellington TD, Miller JW, Henley SJ, Wilson RJ, Wu, M, Richardson LC. Trends in breast cancer incidence, by race, ethnicity, and age among women aged ≥ 20 years—United States, 1999–2018. MMWR 2022;71(2):43. 10.15585/mmwr.mm7102a2
Liao CI, Francoeur AA, Kapp DS, Caesar MAP, Huh WK, Chan JK. Trends in human papillomavirus–associated cancers, demographic characteristics, and vaccinations in the US, 2001–2017. JAMA Network Open 2022;5(3):.e222530–e222530. 10.1001/jamanetworkopen.2022.2530
Melkonian SC, Jim MA, Pete D, Poel A, Dominguez, AE, Echo‐Hawk A, Zhang S, Wilson RJ, Haverkamp D, Petras, L, Pohlenz A. Cancer disparities among non‐Hispanic urban American Indian and Alaska Native populations in the United States, 1999–2017. Cancer 2022;128(8):1626–1636. 10.1002/cncr.34122
Minihan AK, Patel AV, Flanders WD, Goding Sauer A, Jemal A, Islami F. Proportion of cancer cases attributable to physical inactivity by US state, 2013–2016. Medicine and Science in Sports and Exercise 2022;54(3):417–423. 10.1249/mss.0000000000002801
Raza SA, da Costa WL, Thrift AP. Increasing incidence of gallbladder cancer among non-Hispanic Blacks in the United States: a birth cohort phenomenon. Cancer Epidemiology, Biomarkers and Prevention 2022. 10.1158/1055-9965.epi-21-1452
Shah RR, Millien VO, da Costa WL, Oluyomi AO, Gould Suarez M, Thrift AP. Trends in the incidence of early-onset colorectal cancer in all 50 United States from 2001 through 2017. Cancer 2022;128(2):299–310. 10.1002/cncr.33916

Ackroyd SA, Shih YC, Kim B, Lee NK, Halpern MT. A look at the gynecologic oncologist workforce—are we meeting patient demand? Gynecologic Oncology 2021;163(2):229–236. 10.1016/j.ygyno.2021.08.013
Barlass U, Deshmukh A, Beck T, Bishehsari F. Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases. PLoS ONE 2021;16(1):e0244285. 10.1371/journal.pone.0244285
Bartley SJ, Wu M, Benard V, Ambrosone C, Richardson LC. Are there regional differences in triple negative breast cancer among non-Hispanic Black women? Journal of the National Medical Association 2021;113(3):353–356. 10.1016/j.jnma.2020.07.016
Boakye EA, Babatunde OA, Wang M, Osazuwa-Peters N, Jenkins W, Lee M, Kim M. Geographic variation in human papillomavirus vaccination initiation and completion among young adults in the U.S. American Journal of Preventive Medicine 2021;60(3):387–396. 10.1016/j.amepre.2020.09.005
Cho MY, Siegel DA, Demb J, Richardson LC, Gupta S. Increasing colorectal cancer incidence before and after age 50: implications for screening initiation and promotion of “on-time” screening. Digital Diseases and Science 2021. 10.1007/s10620-021-07213-w
Deshmukh AA, Suk R, Shiels MS, Damgacioglu H, Lin YY, Stier EA, Nyitray AG, Chiao EY, Nemutlu GS, Chhatwal J, Schmeler K, Sigel K, Sonawane K. Incidence trends and burden of human papillomavirus-associated cancers among women in the United States, 2001–2017. JNCI: Journal of the National Cancer Institute 2021;113(6):792–796. 10.1093/jnci/djaa128
Ellington, TD, Henley, SJ, Wilson, RJ, Wu, M, Richardson, LC. Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial‐ethnic group, United States 2003–2016. Cancer Medicine 2021;10(1):386–395. 10.1002/cam4.3444
Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of incidence, prevalence, survival, and initial treatment in patients with non–small cell lung cancer in the US. JAMA Oncology 2021;7(12):1824–1832. 10.1001/jamaoncol.2021.4932
Islami F, Bandi P, Sahar L, Ma J, Drope J, Jemal A. Cancer deaths attributable to cigarette smoking in 152 U.S. metropolitan or micropolitan statistical areas, 2013–2017. Cancer Causes and Control 2021;32:311–316. 10.1007/s10552-020-01385-y
Jemal A Culp MB, Ma J, Islami F, Fedewa SA. Prostate cancer incidence 5 years after US Preventive Services Task Force recommendations against screening. Journal of the National Cancer Institute 2021;113(1):64–71. 10.1093/jnci/djaa068
Liao C, Manrriquez E, Chan C, Argueta C, Kapp D, Chan J. Cervical cancer trends in Hispanic subgroups: who is most at risk? Gynecologic Oncology 2021;162(1):S105. 10.1016/S0090-8258(21)00843-X
Mix JM, Van Dyne EA, Saraiya M, Hallowell BD and Thomas CC. Assessing impact of HPV vaccination on cervical cancer incidence among women aged 15–29 years in the United States, 1999–2017: An ecologic study. Cancer Epidemiology, Biomarkers and Prevention 2021;30(1):30–37. 10.1158/1055-9965.EPI-20-0846
Moss JL, Wang M, Liang M, Kameni A, Stoltzfus KC, Onega T. County-level characteristics associated with incidence, late-stage incidence, and mortality from screenable cancers. Cancer Epidemiology 2021;75:102033. 10.1016/j.canep.2021.102033.
Reece AS, Hulse GK. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates. BMC Cancer 2021;21:197. 10.1186/s12885-021-07924-3
Spencer JB. How sparing is fertility-sparing surgery for early-stage cervical cancer? Fertility and Sterility 2021;115(5):1168–1169. 10.1016/j.fertnstert.2021.03.012
Turbow SD, White MC, Breslau ES, Sabatino SA. Mammography use and breast cancer incidence among older U.S. women. Breast Cancer Research and Treatment 2021;188(1):307–316. 10.1007/s10549-021-06160-4
Varma T, Wallach JD, Miller JE, Schnabel D, Skydel JJ, Zhang AD, Dinan MA, Ross JS, Gross CP. Reporting of study participant demographic characteristics and demographic representation in premarketing and postmarketing studies of novel cancer therapeutics. JAMA Network Open 2021;4(4):e217063. 10.1001/jamanetworkopen.2021.7063

Alattas M, Ross CS, Henehan ER, Naimi TS. Alcohol policies and alcohol-attributable cancer mortality in U.S. states. Chemico-Biological Interactions 2020;315. 10.1016/j.cbi.2019.108885
Culp MB, Benard V, Dowling NF, King J, Lu H, Rao C, Scott LC, Wilson R, Wu M. Ocular melanoma incidence rates and trends in the United States, 2001–2016. Eye 2021;35(2):687–689. 10.1038/s41433-020-0885-1
Das P, Soni P, Jones J, Habboub G, Barnholtz-Sloan JS, Recinos PF, Kshettry VR. Descriptive epidemiology of chordomas in the United States. Journal of Neuro-oncology 2020;148(1):173–178. 10.1007/s11060-020-03511-x
Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, Gaisa MM, Palefsky JM, Sigel K. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015. Journal of the National Cancer Institute 2020;112(8):829–838. 10.1093/jnci/djz219
Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, Lathia JD, Rubin JB, Berens ME, Connor J, Barnholtz-Sloan JS. Sex differences in cancer incidence and survival: A pan-cancer analysis. Cancer Epidemiology, Biomarkers and Prevention 2020; 29(7):1389–1397. 10.1158/1055-9965.EPI-20-0036
Ellington TD, Henley SJ, Senkomago V, O’Neil ME, Wilson RJ, Singh S, Thomas CC, Wu M, Richardson LC. Trends in incidence of cancers of the oral cavity and pharynx—United States, 2007–2016. MMWR Morbidity and Mortality Weekly Report 2020;69:433–438. 15585/mmwr.mm6915a1
Ellington TD, Henley SJ, Wilson RJ, Miller JW. Breast cancer survival among males by race, ethnicity, age, geographic region, and stage—United States, 2007–2016. MMWR Morbidity and Mortality Weekly Report 2020;69(41):1481–1484. 10.15585/mmwr.mm6941a2
Gopalani SV, Janitz AE, Martinez SA, Gutman P, Khan S, Campbell JE. Trends in cancer incidence among American Indians and Alaska Natives and non-Hispanic Whites in the United States, 1999–2015. Cancer 2020;31(2):205–213. 10.1097/EDE.0000000000001140
Henley SJ, Peipins LA, Rim SH, Larson TC, Miller JW. Geographic co-occurrence of mesothelioma and ovarian cancer incidence. Journal of Women’s Health 2020;29(1):111–118. 1089/jwh.2019.7752
Iyengar S, Hall IJ, Sabatino SA. Racial/ethnic disparities in prostate cancer incidence, distant stage diagnosis, and mortality by U.S. census region and age-group, 2012–2015. Cancer Epidemiology, Biomarkers and Prevention 2020;29(7):1357–1364. 1158/1055-9965.EPI-19-1344
Jemal A, Culp MB, Ma J, Islami F, Fedewa SA. Prostate cancer incidence 5 years after US Preventive Services Task Force recommendations against screening. JNCI: Journal of the National Cancer Institute 2020;113(1):64–71. 10.1093/jnci/djaa068
Khan N, Tomar SL. The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015. Journal of the American Dental Association 2020;151(1):51–58. 1016/j.adaj.2019.08.022
Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL. Cancer statistics for adolescents and young adults, 2020. CA: A Cancer Journal for Clinicians 2020;70(6):443–459. 10.3322/caac.21637
Paulson KG, Gupta D, Kim TS, Veatch JR, Byrd DR, Bhatia S, Wojcik K, Chapuis AG, Thompson JA, Madeleine MM, Gardner JM. Age-specific incidence of melanoma in the United States. Journal of the American Medical Association Dermatology 2020;156(1):57–64. 1001/jamadermatol.2019.3353
Shah UA, Shah N, Qiao B, Acuna-Villaorduna A, Pradhan K, Adrianzen Herrera D, Sica RA, Shastri A, Mantzaris I, Derman O, Kornblum N, Braunschweig I, Ye BH, Verma A, Janakiram M. Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States. Cancer 2020;126(3):567–574. 1002/cncr.32556
Siegel DA, O’Neil ME, Richards TB, Dowling NF, Weir HK. Prostate cancer incidence and survival, by stage and race/ethnicity—United States, 2001–2017. MMWR Morbidity and Mortality Weekly Report 2020;69:1473–1480. 10.15585/mmwr.mm6941a1
Tavakkoli, A, Singal, AG, Waljee, AK, Elmunzer BJ, Pruitt SL, T McKey, Rubenstein JH, Scheiman JM, Murphy CC. Racial disparities and trends in pancreatic cancer incidence and mortality in the United States. Clinical Gastroenterology and Hepatology 2020;18(1):171–178. 1016/j.cgh.2019.05.059
Thrift AP, El-Serag HB. Burden of gastric cancer. Clinical Gastroenterology and Hepatology 2020;18(3):534–542. 1016/j.cgh.2019.07.045
Thrift AP, Gudenkauf FJ. Melanoma incidence among non-Hispanic Whites in all 50 US states from 2001 through 2015. JNCI: Journal of the National Cancer Institute 2020;112(5):533–539. 10.1093/jnci/djz153
Zhang X, El-Serag HB, Thrift AP. Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age-period-cohort analysis. Cancer Epidemiology, Biomarkers and Prevention 2020;29(1):88–94. 1158/1055-9965.EPI-19-1052

Culp MB, Lunsford NB. Melanoma among non-Hispanic Black Americans. Preventing Chronic Disease 2019;16:180640. 10.5888/pcd16.180640
Eberth JM, Zahnd WE, Adams SA, Friedman DB, Wheeler SB, Hebert JR. Mortality-to-incidence ratios by US Congressional district: Implications for epidemiologic, dissemination and implementation research, and public health policy. Preventive Medicine 2019;129S:105849. 1016/j.ypmed.2019.105849
Freeman MB, Holman DM, Lunsford NB. Merkel cell carcinoma incidence, trends, and survival rates among adults aged ≥50 years from United States Cancer Statistics. Journal of American Academy of Dermatology 2019;80(4):1154–1156. 10.1016/j.jaad.2018.10.045
Gallaway MS, Berens AS, Puckett MC, Foster S. Understanding geographic variations of indoor radon potential for comprehensive cancer control planning. Cancer Causes and Control 2019;30(7):707–712. 1007/s10552-019-01162-6
Guo F, Kuo Y, Berenson AB. Breast cancer incidence by stage before and after change in screening guidelines. American Journal of Preventive Medicine 2019;56(1):100–108. 10.1016/j.amepre.2018.08.018
Hopkins ZH, Moreno C, Carlisle R, Secrest AM. Melanoma prognosis in the United States: Identifying barriers for improved care. Journal of the American Academy of Dermatology 2019;80(5):256–262. 10.1016/j.jaad.2019.01.003
Hsu CH, Chan JK, Yin CH, Lee CC, Chern CU, Liao CI. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States. PLoS One 2019;14(12):e0227197. 1371/journal.pone.0227197
Islami F, Fedewa SA, Jemal A. Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States. Preventive Medicine 2019;123:316-323. 1016/j.ypmed.2019.04.010
Islami F, Sauer AG, Gapstru SM, Jemal A. Proportion of cancer cases attributable to excess body weight by US state, 2011–2015. JAMA Oncology 2019;5(3):384–392. 10.1001/jamaoncol.2018.5639
Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L, Yabroff R, Shulman L, Facktor M, Winchester DP, Nelson H. Incident cases captured in the National Cancer Database compared with those in U.S. population-based central cancer registries in 2012–2014. Annals of Surgical Oncology 2019;26(6):1604–1612. 10.1245/s10434-019-07213-1
Melkonian SC, Jim MA, Haverkamp D, Wiggins CL, McCollum J, White MC, Kaur JS, Espey DK. Disparities in cancer incidence and trends among American Indians and Alaska Natives in the United States, 2010–2015. Cancer Epidemiology, Biomarkers and Prevention 2019;28(10):1604-1611. 1158/1055-9965.EPI-19-0288
Morgenstern H, Longstreth K. Clustering of esophageal cancer among White men in the United States. Diseases of the Esophagus 2019;32(1):doy081. 10.1093/dote/doy081
O’Neil ME, Henley SJ, Rohan EA, Ellington TD, Gallaway MS. Lung cancer incidence in nonmetropolitan and metropolitan counties—United States, 2007–2016. MMWR 2019;68(44):993–998. 15585/mmwr.mm6844a1
Patel N, Benipal B. Incidence of gastrointestinal stromal tumors in the United States from 2001-2015: A United States Cancer Statistics analysis of 50 States. Cureus 2019;11(2):e4120. 7759/cureus.4120
Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology 2019;156(1):254-272. 1053/j.gastro.2018.08.063
Scott LC, Barker LE, Richardson LC. Using population health measures to evaluate the environmental burden of cancer at the county level. Preventing Chronic Disease 2019;16:E45. 5888/pcd16.180530
Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus–attributable cancers—United States, 2012–2016. MMWR 2019;68(33):724–728. 15585/mmwr.mm6833a3
Siegel, DA, Li, J, Ding, H, Singh, SD, King, JB, Pollack, LA. Racial and ethnic differences in survival of pediatric patients with brain and central nervous system cancer in the United States. Pediatric Blood and Cancer 2019;66(2):e27501. 10.1002/pbc.27501

Boscoe F, Hutchison L. Differential reporting of in situ colorectal cancer in New York State and the United States. Journal of Registry Management 2018;45(1):33–36.
Gallaway MS, Henley SJ, Steele CB, Momin B, Thomas CC, Jamal A, Trivers KF, Singh SD, Stewart SL. Surveillance of cancers associated with tobacco use—United States, 2010–2014. MMWR Surveillance Summaries 2018;67(12)1–42. 10.15585/mmwr.ss6712a1
Garcia S, Pruitt S, Singal AG, Murphy CC. Colorectal cancer incidence among Hispanics and non-Hispanic Whites in the United States. Cancer Causes and Control 2018;29(11):1039–1046. 10.1007/s10552-018-1077-1
Gopalani S, Janitz AE, Campbell JE. Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999–2013. Cancer Epidemiology 2018;56:140–145. 10.1016/j.canep.2018.08.008
Guo F, Cofie LE, Berenson AB. Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction. American Journal of Preventive Medicine 2018;55(2):197–204. 10.1016/j.amepre.2018.03.013
Henley SJ, Miller JW, Dowling NF, Benard VB, Richardson LC. Uterine cancer incidence and mortality—United States, 1999–2016. MMWR 2018;67(48)1333–1338. 10.15585/mmwr.mm6748a1
Holman DM, Freeman MB, Shoemaker ML. Trends in melanoma incidence among non-Hispanic Whites in the United States, 2005 to 2014. JAMA Dermatology 2018;154(3):361–362. 10.1001/jamadermatol.2017.5541
Houston KA, Mitchell KA, King J, White A, Ryan BM. Histologic lung cancer incidence rates and trends vary by race/ethnicity and residential county. Journal of Thoracic Oncology 2018;13(4):497–509. 10.1016/j.jtho.2017.12.010
Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, McCullough ML, Patel AV, Ma J, Soerjomataram I, Flanders WD, Brawley OW, Gapstur SM, Jemal A. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA: A Cancer Journal for Clinicians 2018;68(1):31–54. 10.3322/caac.21440
Li J, Siegel DA, King JB. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004–2014. Annals of Epidemiology 2018;28(5):328–330. 10.1016/j.annepidem.2018.03.001
Liao CI, Chow S, Chen LM, Kapp DS, Mann A, Chan JK. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the U.S. Gynecologic Oncology 2018;149(2):318–323. 10.1016/j.ygyno.2018.01.030
Melkonian SC, Jim MA, Reilley B, Erdrich J, Berkowitz Z, Wiggins CL, Haverkamp D, White MC. Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999–2009. Cancer Causes and Control 2018;29(9):833–844. 10.1007/s10552-018-1059-3
Patel N, Benipal B. Incidence of esophageal cancer in the United States from 2001–2015: A United States Cancer Statistics analysis of 50 states. Cureus 2018;10(12):e3709. 10.7759/cureus.3709
Shoemaker ML, White MC, Wu M, Weir HK, Romieu I. Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013. Breast Cancer Research and Treatment 2018;169(3):595–606. 10.1007/s10549-018-4699-9
Siegel DA, Li J, Henley SJ, Wilson RJ, Lunsford NB, Tai E, Van Dyne EA. Geographic variation in pediatric cancer incidence—United States, 2003–2014. MMWR 2018;67(25):707–713. 10.15585/mmwr.mm6725a2
Van Dyne EA, Henley SJ, Saraiya M, Thomas CC, Markowitz LE, Benard VB. Trends in human papillomavirus-associated cancers—United States, 1999–2015. MMWR 2018;67(33):918–924. 10.15585/mmwr.mm6733a2
Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. International Journal of Epidemiology 2018;47(3):966–975. 10.1093/ije/dyy055

Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive cancer incidence, 2004–2013, and deaths, 2006–2015, in nonmetropolitan and metropolitan counties—United States. MMWR Surveillance Summaries 2017;66(14):1–13. 10.15585/mmwr.ss6614a1
Henley SJ, Singh SD, King J, Wilson RJ, O’Neil ME, Ryerson AB. Invasive cancer incidence and survival—United States, 2013. MMWR 2017;66(3):69–75. 10.15585/mmwr.mm6603a1
Houston KA, King J, Li J, Jemal A. Trends in prostate cancer incidence rates and prevalence of prostate specific antigen screening by socioeconomic status and regions in the United States, 2004 to 2013. The Journal of Urology 2017;199(3):676–682. 10.1016/j.juro.2017.09.103
Siegel DA, Henley SJ, Li J, Pollack LA, Van Dyne EA, White A. Rates and trends of pediatric acute lymphoblastic leukemia—United States, 2001–2014. MMWR 2017;66(36):950–954. 10.15585/mmwr.mm6636a3
Singh SD, Henley SJ, Ryerson AB. Surveillance for cancer incidence and mortality—United States, 2013. MMWR Surveillance Summaries 2017;66(4):1–36. 10.15585/mmwr.ss6604a1
Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, Puckett M, Richardson LC. Vital Signs: Trends in incidence of cancers associated with overweight and obesity—United States, 2005–2014. MMWR 2017;66(39):1052–1058. 10.15585/mmwr.mm6639e1

Garnett E, Townsend J, Steele B, Watson M. Characteristics, rates, and trends of melanoma incidence among Hispanics in the USA. Cancer Causes and Control 2016;27(5):647–659. 10.1007/s10552-016-0738-1
Henley SJ, Thomas CC, Sharapova SR, Momin B, Massetti GM, Winn DM, Armour BS, Richardson LC. Vital Signs: Disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013. MMWR 2016;65(44):1212–1218. 10.15585/mmwr.mm6544a3
Richardson LC, Henley SJ, Miller JW, Massetti G, Thomas CC. Patterns and trends in age-specific Black-White differences in breast cancer incidence and mortality—United States, 1999–2014. MMWR 2016;65(40):1093–1098. 10.15585/mmwr.mm6540a1
Singh SD, Henley SJ, Ryerson AB. Surveillance for cancer incidence and mortality—United States, 2012. MMWR 2016;63(55):17–58. 10.15585/mmwr.mm6355a4
Watson M, Geller AC, Tucker MA, Guy GP Jr, Weinstock MA. Melanoma burden and recent trends among non-Hispanic Whites aged 15–49 years, United States. Preventive Medicine 2016;91:294–298. 10.1016/j.ypmed.2016.08.032
Wilson RJ, Ryerson AB, Singh SD, King JB. Cancer incidence in Appalachia, 2004–2011. Cancer Epidemiology, Biomarkers and Prevention 2016;25(2):250–258. 10.1158/1055-9965.EPI-15-0946

Henley SJ, Singh SD, King J, Wilson R, O’Neil ME, Ryerson AB, Centers for Disease Control and Prevention. Invasive cancer incidence and survival—United States, 2011. MMWR 2015;64(9):237–242.
Henley SJ, Singh SD, King J, Wilson RJ, O’Neil ME, Ryerson AB. Invasive cancer incidence and survival—United States, 2012. MMWR 2015;64(49):1353–8. 10.15585/mmwr.mm6449a1
Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. Gallbladder cancer incidence and mortality, United States, 1999–2011. Cancer Epidemiology, Biomarkers and Prevention 2015;24(9):1319–1326. 10.1158/1055-9965.EPI-15-0199
O’Neil ME, Henley SJ, Singh SD, Wilson RJ, Ortiz-Ortiz KJ, Rios NP, Torres Cintron CR, Luna GT, Zavala Zegarra DE, Ryerson AB, Centers for Disease Control and Prevention. Invasive cancer incidence—Puerto Rico, 2007–2011. MMWR 2015;64(14):389–393.
Singh SD, Henley SJ, Ryerson AB. Summary of notifiable noninfectious conditions and disease outbreaks: surveillance for cancer incidence and mortality—United States, 2011. MMWR 2015;62(54):11–51. 10.15585/mmwr.mm6254a3

Austin H, Henley SJ, King J, Richardson LC, Eheman C. Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening? Cancer Causes and Control 2014;25(2):191–201. 10.1007/s10552-013-0321-y
Henley SJ, Richards TB, Underwood JM, Eheman CR, Plescia M, McAfee TA, Centers for Disease Control and Prevention. Lung cancer incidence trends among men and women—United States, 2005–2009. MMWR 2014;63(1):1–5.
Henley SJ, Singh S, King J, Wilson R, Ryerson B, Centers for Disease Control and Prevention. Invasive cancer incidence—United States, 2010. MMWR 2014;63(12):253–259.
Houston KA, Henley SJ, Li J, White MC, Richards TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer 2014;86(1):22–28. 10.1016/j.lungcan.2014.08.001
King SC, Pollack LA, Li J, King JB, Master VA. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. Journal of Urology 2014. 10.1016/j.juro.2013.12.046
Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics 2014;134(4):e945–e955. 10.1542/peds.2013-3926
Singh SD, Ryerson AB, Wu M, Kaur JS. Ovarian and uterine cancer incidence and mortality in American Indian and Alaska Native women, United States, 1999–2009. American Journal of Public Health 2014;104(S3):S423–S431. 10.2105/AJPH.2013.301781
Watson M, Benard V, Thomas C, Brayboy A, Paisano R, Becker T. Cervical cancer incidence and mortality among American Indian and Alaska Native women, 1999–2009. American Journal of Public Health 2014;104(S3):S415–S422. 10.2105/AJPH.2013.301681

Drahos J, Wu M, Anderson WF, Trivers KF, King J, Rosenberg PS, Eheman C, Cook MB. Regional variations in esophageal cancer rates by census region in the United States, 1999–2008. PLoS One 2013;8(7):e67913. 10.1371/journal.pone.0067913
Duong LM, Richardson LC. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999–2008. Journal of Registry Management 2013;40(2):59–64.
Henley SJ, Larson TC, Wu M, Antao VC, Lewis M, Pinheiro GA, Eheman C. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008. International Journal of Occupational and Environmental Health 2013;19(1):1–10. 10.1179/2049396712Y.0000000016

Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, Ajani UA. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004–2007. Cancer 2012;118(17):4220–4227. 10.1002/cncr.27390
Li J, German R, King J, Joseph D, Thompson T, Wu XC, Ajani U, Tai E. Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiology 2012;36(2):122–127. 10.1016/j.canep.2011.10.014
Myles ZM, Buchanan N, King JB, Singh S, White A, Wu M, Ajani U. Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998–2007. Archives of Dermatology 2012;148(7):797–801. 10.1001/archdermatol.2011.3227

Duong LM, Wilson RJ, Ajani UA, Singh SD, Eheman CR. Trends in endometrial cancer incidence rates in the United States, 1999–2006. Journal of Women’s Health 2011;20(8):1157–1163. 10.1089/jwh.2010.2529
Henley SJ, Eheman CR, Richardson LC, Plescia M, Asman KJ, Dube SR, Caraballo RS, McAfee TA. State-specific trends in lung cancer incidence and smoking—United States, 1999–2008. MMWR 2011;60(36):1243–1247.
Holman DM, Soman A, Watson M, Weir HK, Trivers KF, White MC. Examination of the increase in thyroid cancer incidence among younger women in the United States by age, race, geography, and tumor size, 1999–2007. Journal of Adolescent and Young Adult Oncology 2011;1(2):95–102. 10.1089/jayao.2011.0014
Watson M, Johnson CJ, Chen VW, Thomas CC, Weir HK, Sherman R, Cockburn M, Jackson-Thompson J, Saraiya M. Melanoma surveillance in the United States: overview of methods. Journal of the American Academy of Dermatology 2011;65(5S1):S6–S16. 10.1016/j.jaad.2011.04.037
Wong CA, Jim MA, King J, Tom-Orme L, Henderson JA, Saraiya M, Richardson LC, Layne L, Suryaprasad A, Espey DK. Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999–2004. Cancer Causes and Control 2011;22(12):1681–1689. 10.1007/s10552-011-9844-2
Wu XC, Eide MJ, King J, Saraiya M, Huang Y, Wiggins C, Barnholtz-Sloan JS, Martin N, Cokkinides V, Miller J, Patel P, Ekwueme DU, Kim J. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999–2006. Journal of the American Academy of Dermatology 2011;65(5S1):S26–37. 10.1016/j.jaad.2011.05.034

Centers for Disease Cancer and Prevention. Racial/ethnic disparities and geographic differences in lung cancer incidence—38 states and the District of Columbia, 1998–2006. MMWR 2010;59(44):1434–1438.
Henley SJ, King JB, German RR, Richardson LC, Plescia M, Centers for Disease Control and Prevention. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix)—United States, 2004–2006. MMWR Surveillance Summaries 2010;59(SS09):1-25.
Townsend JS, Richardson LC, German RR. Incidence of testicular cancer in the United States, 1999–2004. American Journal of Men’s Health 2010;4(4):353–360. 10.1177/1557988309356101

Duong LM, Ajani UA, Wilson RJ. Comparative evaluation of uterine cancer staging data using two different staging systems, 2001–2005. Journal of Registry Management 2009;36(4):125–129.
Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA,White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004. Cancer Epidemiology, Biomarkers and Prevention 2009;18(6):1763–1769. 10.1158/1055-9965.EPI-08-1082
Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States, 1999–2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009;115(9):1967–1976. 10.1002/cncr.24216
Sabatino SA, Stewart SL, Wilson RJ. Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001–2003. Journal of Women’s Health) 2009;18(3):285–294. 10.1089/jwh.2008.1171

Becker TM, Espey DK, Lawson HW, Saraiya M, Jim MA, Waxman AG. Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999–2004. Cancer 2008;113(5S):1234–1243. 10.1002/cncr.23736
Bliss A, Cobb N, Solomon T, Cravatt K, Jim MA, Marshall L, Campbell J. Lung cancer incidence among American Indians and Alaska Natives in the United States, 1999–2004. Cancer 2008;113(5S):1168–1178. 10.1002/cncr.23738
Henderson JA, Espey DK, Jim MA, German RR, Shaw KM, Hoffman RM. Prostate cancer incidence among American Indian and Alaska Native men, U.S., 1999–2004. Cancer 2008;113(5S):1203–1212. 10.1002/cncr.23739
Jim MA, Perdue DG, Richardson LC, Espey DK, Redd JT, Martin HJ, Kwong SL, Kelly JJ, Henderson JA, Ahmed F. Primary liver cancer incidence among American Indians and Alaska Natives, U.S., 1999–2004. Cancer 2008;113(5S):1244–1255. 10.1002/cncr.23728
Lemrow SM, Perdue DG, Stewart SL, Richardson LC, Jim MA, French HT, Swan J, Edwards BK, Wiggins C, Dickie L, Espey DK. Gallbladder cancer incidence among American Indians and Alaska Natives, U.S., 1999–2004. Cancer 2008;113(5S):1266–1273. 10.1002/cncr.23737
Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics 2008;121(6):e1470–e1477. 10.1542/peds.2007-2964
Perdue DG, Perkins C, Jackson-Thompson J, Coughlin SS, Ahmed F, Haverkamp DS, Jim MA. Regional differences in colorectal cancer incidence, stage, and subsite among American Indians and Alaska Natives, 1999–2004. Cancer 2008;113(5S):1179–1190. 10.1002/cncr.23726
Reichman ME, Kelly JJ, Kosary CL, Coughlin SS, Jim MA, Lanier AP. Incidence of cancers of the oral cavity and pharynx among American Indians and Alaska Natives, 1999–2004. Cancer 2008;113(5S):1256–1265. 10.1002/cncr.23735
Stewart SL, Cardinez CJ, Richardson LC, Norman L, Kaufmann R, Pechacek TF, Thompson TD, Weir HK, Sabatino SA, Centers for Disease Control and Prevention. Surveillance for cancers associated with tobacco use—United States, 1999–2004. MMWR Surveillance Summaries 2008;57(SS08):1-33.
Trivers KF, Sabatino SA , Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003. International Journal of Cancer 2008;123(6):1422–1428. 10.1002/ijc.23691
Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 2008;113(10S):2841–2854. 10.1002/cncr.23758
Weir HK, Jim MA, Marrett LD, Fairley T. Cancer in American Indian and Alaska Native young adults (ages 20–44 years): U.S., 1999–2004. Cancer 2008;113(5S):1153–1167. 10.1002/cncr.23731
Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J, Miller BA, Jim MA, Kelly JJ, Lanier AP. Cancer among American Indians and Alaska Natives in the United States, 1999–2004. Cancer 2008;113(5S):1142–1152. 10.1002/cncr.23734
Wiggins CL, Perdue DG, Henderson JA, Bruce MG, Lanier AP, Kelley JJ, Seals BF, Espey DK. Gastric cancer among American Indians and Alaska Natives in the United States, 1999–2004. Cancer 2008;113(5S):1225–1233. 10.1002/cncr.23732
Wilson RT, Richardson LC, Kelly JJ, Kaur J, Jim MA, Lanier AP. Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999–2004. Cancer 2008;113(5S):1213–1224. 10.1002/cncr.23733
Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG. Breast cancer incidence among American Indian and Alaska Native women: U.S., 1999–2004. Cancer 2008;113(5S):1191–1202. 10.1002/cncr.23725
Wingo PA, Tucker TC, Jamison PM, Martin H, McLaughlin C, Bayakly R, Bolick-Aldrich S, Colsher P, Indian R, Knight K, Neloms S, Wilson R, Richards TB. Cancer in Appalachia, 2001–2003. Cancer 2008;112(1):181–192. 10.1002/cncr.23132

Benard VB, Coughlin SS, Thompson T, Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998–2001. Obstetrics and Gynecology 2007;110(3):681–686. 10.1097/01.AOG.0000279449.74780.81
Larson T, Melnikova N, Davis SI, Jamison P. Incidence and descriptive epidemiology of mesothelioma in the United States, 1999–2002. International Journal of Occupational and Environmental Health 2007;13(4):3982–3403. 10.1179/oeh.2007.13.4.398
Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998–2002. Obstetrics and Gynecology 2007;109(2):362–370. 10.1097/01.AOG.0000254165.92653.e8
Stewart SL, Sabatino SA, Foster SL, Richardson LC. Decline in breast cancer incidence—United States, 1999–2003. MMWR 2007;56(22):549–553.
Stewart SL, Wike JM, Foster SL, Michaud F. The incidence of primary fallopian tube cancer in the United States. Gynecologic Oncology 2007;107(3):392–397. 10.1016/j.ygyno.2007.09.018

Coughlin SS, Richards TB, Thompson T, Miller BA, VanEenwyk J, Goodman MT, Sherman RL. Rural/nonrural differences in colorectal cancer incidence in the United States, 1998–2001. Cancer 2006;107(5S):1181–1188. 10.1002/cncr.22015
Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, Jamison P. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001. Cancer 2006;107(5S):1153–1161. 10.1002/cncr.22012
Jackson-Thompson J, Ahmed F, German RR, Lai SM, Friedman C. Descriptive epidemiology of colorectal cancer in the United States, 1998–2001. Cancer 2006;107(5S):1103–1111. 10.1002/cncr.22007
Lai SM, Zhang KB, Uhler RJ, Harrison JN, Clutter GG, Williams MA. Geographic variation in the incidence of colorectal cancer in the United States, 1998–2001. Cancer 2006;107(5S):1172–1180. 10.1002/cncr.22014
Matanoski G, Tao X, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998–2001. Cancer 2006;107(5S):1112–1120. 10.1002/cncr.22008
Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer 2006;107(5S):1128–1141. 10.1002/cncr.22010
Wu X, Cokkinides V, Chen VW, Nadel M, Ren Y, Martin J, Ellison GL. Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex. Cancer 2006;107(5S):1121–1127. 10.1002/cncr.22009

Publications That Use U.S. Cancer Statistics Data

Stat Bites

Current U.S. Cancer Statistics Data Briefs

Selected Journal Articles

Stay Informed